CAMK2B and triple-negative breast carcinoma: Furthermore, when the CAMK2 genes were examined independently, high CAMK2A mRNA expression was associated with significantly worse overall (p = 0.01, p = 0.01007, p = 0.01) and distant metastasis free survival (p = 0.05, p = 0.02434, p = 0.01) in Luminal A, Luminal B, and triple negative breast cancer subtypes, respectively.